GB2074028B - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB2074028B
GB2074028B GB8109926A GB8109926A GB2074028B GB 2074028 B GB2074028 B GB 2074028B GB 8109926 A GB8109926 A GB 8109926A GB 8109926 A GB8109926 A GB 8109926A GB 2074028 B GB2074028 B GB 2074028B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8109926A
Other versions
GB2074028A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GB2074028A publication Critical patent/GB2074028A/en
Application granted granted Critical
Publication of GB2074028B publication Critical patent/GB2074028B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
GB8109926A 1980-03-31 1981-03-30 Pharmaceutical formulations Expired GB2074028B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (2)

Publication Number Publication Date
GB2074028A GB2074028A (en) 1981-10-28
GB2074028B true GB2074028B (en) 1983-09-21

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8109926A Expired GB2074028B (en) 1980-03-31 1981-03-30 Pharmaceutical formulations

Country Status (30)

Country Link
JP (1) JPS56152415A (en)
KR (1) KR860000841B1 (en)
AR (1) AR225500A1 (en)
AT (1) AT370996B (en)
AU (1) AU541056B2 (en)
BE (1) BE888209A (en)
CA (1) CA1162479A (en)
CH (1) CH647481A5 (en)
CS (1) CS246051B2 (en)
DD (1) DD157762A5 (en)
DE (1) DE3112272A1 (en)
DK (1) DK158564C (en)
ES (1) ES8206545A1 (en)
FI (1) FI70670C (en)
FR (1) FR2480605A1 (en)
GB (1) GB2074028B (en)
GR (1) GR72769B (en)
HU (1) HU183379B (en)
IE (1) IE51070B1 (en)
IL (1) IL62517A (en)
IT (1) IT1170838B (en)
LU (1) LU83270A1 (en)
NL (1) NL8101531A (en)
NO (1) NO156675C (en)
NZ (1) NZ196519A (en)
PH (1) PH17152A (en)
PT (1) PT72774B (en)
SE (1) SE455045B (en)
SU (1) SU1056893A3 (en)
ZA (1) ZA812084B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (en) * 1982-09-23 1987-01-21 Erba Farmitalia PHARMACOLOGICAL COMPOSITIONS BASED ON CISPLATIN AND METHOD FOR THEIR OBTAINMENT
NL8303657A (en) * 1983-10-24 1985-05-17 Pharmachemie Bv SOLUTION, STABLE, AQUEOUS, AQUEOUS, CONTAINING SOLUTION OF CISPLATINE, AND METHOD OF PREPARING THEREOF.
FI895340A0 (en) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co HYPERTONISK CISPLATIN-LOESNING.
ES2208946T3 (en) * 1996-08-23 2004-06-16 Sequus Pharmaceuticals, Inc. LIPOSOMES CONTAINING A CISPLATIN COMPOUND.
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (en) 2004-03-26 2010-04-07 オンキヨー株式会社 Switching amplifier
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
ES2928931T3 (en) 2018-03-29 2022-11-23 Project Pharmaceutics Gmbh liquid pharmaceutical formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
CA1119954A (en) * 1978-05-30 1982-03-16 Edmund S. Granatek Aqueous solution of cisplatin

Also Published As

Publication number Publication date
AU6816681A (en) 1981-10-08
NZ196519A (en) 1983-06-17
ES500869A0 (en) 1982-08-16
JPS6360008B2 (en) 1988-11-22
KR830004849A (en) 1983-07-20
IL62517A (en) 1984-01-31
NO811081L (en) 1981-10-01
ZA812084B (en) 1982-04-28
DE3112272A1 (en) 1982-04-29
AR225500A1 (en) 1982-03-31
NL8101531A (en) 1981-10-16
FR2480605B1 (en) 1984-05-11
KR860000841B1 (en) 1986-07-09
DK158564B (en) 1990-06-11
PT72774B (en) 1982-11-16
DK158564C (en) 1990-11-05
PT72774A (en) 1981-04-01
PH17152A (en) 1984-06-13
IE810715L (en) 1981-09-30
DD157762A5 (en) 1982-12-08
SE8101990L (en) 1981-11-13
ES8206545A1 (en) 1982-08-16
CA1162479A (en) 1984-02-21
SE455045B (en) 1988-06-20
IL62517A0 (en) 1981-05-20
GR72769B (en) 1983-12-02
SU1056893A3 (en) 1983-11-23
BE888209A (en) 1981-09-30
IT8148090A0 (en) 1981-03-24
FI810934L (en) 1981-10-01
CH647481A5 (en) 1985-01-31
DK144281A (en) 1981-10-01
ATA150481A (en) 1982-10-15
GB2074028A (en) 1981-10-28
IE51070B1 (en) 1986-09-17
NO156675B (en) 1987-07-27
LU83270A1 (en) 1981-10-29
FR2480605A1 (en) 1981-10-23
IT1170838B (en) 1987-06-03
FI70670C (en) 1986-10-06
DE3112272C2 (en) 1990-09-27
AU541056B2 (en) 1984-12-13
FI70670B (en) 1986-06-26
AT370996B (en) 1983-05-25
JPS56152415A (en) 1981-11-26
NO156675C (en) 1987-11-04
CS246051B2 (en) 1986-10-16
HU183379B (en) 1984-04-28

Similar Documents

Publication Publication Date Title
DE3172028D1 (en) Pharmaceutical formulation
DE3378523D1 (en) Pharmaceutical formulations
ZA813465B (en) Pharmaceutical composition
ZA814215B (en) Pharmaceutical preparations
ZA824513B (en) Pharmaceutical formulations
ZA804196B (en) Pharmaceutical formulations
ZA81136B (en) Pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
ZA817679B (en) Novel pharmaceutical preparations
GB2074028B (en) Pharmaceutical formulations
ZA815700B (en) Pharmaceutical compositions
MTP884B (en) Pharmaceutical preparationes
ZA81650B (en) Pharmaceutical preparations
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
ZA817684B (en) Pharmaceutical compositions
ZA817572B (en) Pharmaceutical formulation
ZA815175B (en) Pharmaceutical composition
ZA833692B (en) Pharmaceutical formulations
KE3581A (en) Pharmaceutical formulation
PT73810B (en) Pharmaceutical compositions
ZA812902B (en) Pharmaceutical compositions
ZM8681A1 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940330